U.S. drug reviewers released a report on Tuesday indicating that the use of some contrast agents is riskier than others. According to the report, people who use these drugs have a better chance of contracting certain skin diseases. 

These drugs include GE Healthcare's Omniscan, Bayer AG's Magnevist and Covidien's Optimark. The Food and Drug Administration linked these drugs to such diseases as nephrogenic systemic fibrosis. 

If you or anyone you know has used these contrast agents, contact the gadolinium lawyers of Williams Kherkher at 800-761-3187.